This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

HEV Pathogenesis & Treatment | Rom 715

Thursday, June 14, 2018
4:15 PM to 6:00 PM

Chairs: Heiner Wedemeyer & Jacques Izopet

Invited Presentations:

4:15pm
HEV and emerging worldwide pathogen? Shiv Sarin, Institute Of Liver And Biliary Sciences, New Delhi

4:40pm
Treatment of HEV infection Heiner Wedemeyer, University Hospital Essen, Essen

5:05pm
HEV in immunocompromised patients Ken Sherman, University Of Cincinnati College Of Medicine, Cincinnati

Oral Abstracts:

5:30pm
Hepatitis E - Profile And Predictors Of Mortality: Indian Experience Aradya Venu, St. John’s Medical College Hospital, Bengaluru

5:45pm
Association between liver fibrosis and HEV seroprevalence among HIV-positive individuals in Nepal Jose Debes, University Of Minnesota, Minneapolis